Patent details

301182 Product Name: roxadustat

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
301182
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP3470397
Status:
Application Pending
Application number:
301182
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)

Marketing Authorization

Marketing Authorization Number:
EU/1/21/1574
Marketing Authorization Type:
EEA
Marketing Authorization Date:
19/08/2021
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
24/06/2022
First Marketing Authorization date:
19/08/2021
Grant date:
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
27/06/2022
SPC/SPC Extension Expiration Date:
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
24/06/2022
 
 

 

Name:
Fibrogen, Inc.
Address:
409 Illinois Street, SAN FRANCISCO, CA 94158, United States of America (US)

Agent

1

Name:
ir. B.Ch. Ledeboer c.s
From:
09/01/2025
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:

2

Name:
ir. H.A. Witmans c.s.
From:
24/06/2022
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:
09/01/2025

Publication

Bulletin

Bulletin Heading:
SPC
Journal edition number:
26/22
Publication date:
29/06/2022
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Filing date Document type Document Description Number of pages File Type
31/01/2023 Outgoing Correspondence Letter to applicant 1 PDF /8/5/4/2/0/0800802458/docs/301182_1_493850l173.pdf
27/01/2023 Incoming Correspondence Paper Incoming Correspondence Paper 1 PDF /8/5/4/2/0/0800802458/docs/301182_0_incomingcorrespondencepaper20230130083647717.pdf
27/06/2022 Outgoing Correspondence Confirmation receipt request 1 PDF /8/5/4/2/0/0800802458/docs/301182_2_489786l174.pdf
24/06/2022 SPC Documents Accompanying letter SPC 1 PDF /8/5/4/2/0/0800802458/docs/301182_3_supplprotectioncertificate20220627105732408.pdf
24/06/2022 SPC Documents Annex SPC 26 PDF /8/5/4/2/0/0800802458/docs/301182_4_supplprotectioncertificate20220627105732489.pdf
24/06/2022 SPC Documents Summary of the characteristics of the product 27 PDF /8/5/4/2/0/0800802458/docs/301182_5_supplprotectioncertificate20220627105732453.pdf
24/06/2022 SPC Documents Annex SPC 47 PDF /8/5/4/2/0/0800802458/docs/301182_6_supplprotectioncertificate20220627105732513.pdf
24/06/2022 SPC Documents Annex SPC 2 PDF /8/5/4/2/0/0800802458/docs/301182_7_supplprotectioncertificate20220627105732470.pdf
24/06/2022 SPC Documents Marketing Authorization SPC 3 PDF /8/5/4/2/0/0800802458/docs/301182_8_supplprotectioncertificate20220627105732430.pdf
24/06/2022 Application Form First filed application form 3 PDF /8/5/4/2/0/0800802458/docs/301182_9_applicationform20220627105732360.pdf